The global prostate cancer diagnostics market is forecasted to reach USD 7,112.2 Million by 2027, according to a new report by Reports and Data. The prostate cancer diagnostics market is observing demand attributed to the rising incidence of prostate cancer. It is the most common cause of death occurring as a result of cancer in American men. It has been found that nearly 1 out of 41 men die of prostate cancer. According to recent estimations, around 33,330 men will die of the disease in the year 2020.
Increasing awareness about cancer diagnosis at an early stage is a significant factor driving the market growth. A majority of prostate cancers or about 90.0% cases are detected when the disease is in the prostate gland and the nearby organs, and for such cases, the 5-year survival rate is about 100.0%, whereas the 5-year survival rate for the cases in which the disease has spread to other body parts is 31.0%.
The COVID-19 impact: The COVID-19 pandemic has made it essential to repurpose the operating rooms for surgeries into intensive care units (ICUs) and pushed hospitals to accommodate patients beyond their full capacity of beds. As a result, in several cases, cancer patients’ diagnostics and treatment were categorized as non-urgent. Further, the psychological influence of postponed diagnosis as a result of the COVID-19 pandemic cannot be undermined as when psychological, physical, and social health of patients are handled in a positive way, chances of patients’ survival have been seen to improve from a state of illness towards recovering from the disease. COVID-19 has had a significant and negative impact on cancer treatment and research, making a new health emergency for cancer patients’ management a necessity.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3709
Further key findings from the report suggest
Buy Now: https://www.reportsanddata.com/checkout-form/3709
For the purpose of this report, Reports and Data has segmented into the global prostate cancer diagnostics on the basis of prostate cancer type, test type, end-user, and region:
Prostate Cancer Type Outlook (Revenue, USD Billion; 2017-2027)
Test Type Outlook (Revenue, USD Billion; 2017-2027)
End-User Outlook (Revenue, USD Billion; 2017-2027)
Regional Outlook (Revenue, USD Billion; 2017-2027)
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/prostate-cancer-diagnostics-market
Table Of Content:
Chapter 1. Market Synopsis 1.1. Market Definition 1.2. Research Scope & Premise 1.3. Methodology 1.4. Market Estimation Technique Chapter 2. Executive Summary 2.1. Summary Snapshot, 2019-2027 Chapter 3. Indicative Metrics Chapter 4. Prostate Cancer Diagnostics Market Segmentation & Impact Analysis 4.1. Prostate Cancer Diagnostics Market Material Segmentation Analysis 4.2. Industrial Outlook 4.2.1. Market indicators analysis 4.2.2. Market drivers analysis 4.2.2.1. Rising occurrences of cancer 4.2.2.2. Growing geriatric population
…
Chapter 9. Competitive Landscape 9.1. Market Revenue Share By Manufacturers 9.2. Manufacturing Cost Breakdown Analysis 9.3. Mergers & Acquisitions 9.4. Market positioning 9.5. Strategy Benchmarking 9.6. Vendor Landscape Chapter 10. Company Profiles 10.1. Abbott Laboratories 10.1.1. Company Overview 10.1.2. Financial Performance 10.1.3. Technology Insights 10.1.4. Strategic Initiatives 10.2. Siemens Healthineers 10.2.1. Company Overview 10.2.2. Financial Performance 10.2.3. Technology Insights 10.2.4. Strategic Initiatives 10.3. F. Hoffman La Roche Ltd. 10.3.1. Company Overview 10.3.2. Financial Performance 10.3.3. Technology Insights 10.3.4. Strategic Initiatives 10.4. Danaher Corporation 10.4.1. Company Overview 10.4.2. Financial Performance 10.4.3. Technology Insights 10.4.4. Strategic Initiatives 10.5. Agilent Technologies 10.5.1. Company Overview 10.5.2. Financial Performance 10.5.3. Technology Insights 10.5.4. Strategic Initiatives 10.6. Myriad Genetics Inc. 10.6.1. Company Overview 10.6.2. Financial Performance 10.6.3. Technology Insights 10.6.4. Strategic Initiatives 10.7. Becton, Dickinson, and Company 10.7.1. Company Overview 10.7.2. Financial Performance 10.7.3. Technology Insights 10.7.4. Strategic Initiatives
Continue…
About Us:
Our in-house experts assist our clients with advice based on their proficiency in the market that helps them in creating a compendious database for the clients. Our team offers expert insights to clients to guide them through their business ventures. We put in rigorous efforts to keep our clientele satisfied and focus on fulfilling their demands to make sure that the end-product is what they desire. We excel in diverse fields of the market and with our services extending to competitive analysis, research and development analysis, and demand estimation among others, we can help you invest your funds in the most beneficial areas for research and development.
Media ContactCompany Name: Reports and DataContact Person: John WatsonEmail: Send EmailPhone: +1-212-710-1370Address:40 Wall St. 28th floor City: New York CityState: NY 10005Country: United StatesWebsite: https://www.reportsanddata.com/report-detail/prostate-cancer-diagnostics-market